Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary.

Wouters, Elise; Steenhuis, Maurice; Schrezenmeier, Hubert; Tiberghien, Pierre; Harvala, Heli; Feys, Hendrik B; van der Schoot, Ellen

Wouters, Elise; Steenhuis, Maurice; Schrezenmeier, Hubert; Tiberghien, Pierre; Harvala, Heli; Feys, Hendrik B; van der Schoot, Ellen.

Wouters E; Transfusion Research Center, Belgian Red Cross-Flanders, Ghent, Belgium.
Steenhuis M; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands.
Schrezenmeier H; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
Tiberghien P; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
Harvala H; Etablissement Français du Sang, La Plaine St-Denis, France.
Feys HB; UMR1098 RIGHT, INSERM, Etablissement Français du Sang, Université de Franche-Comté, Besançon, France.
van der Schoot E; Microbiology Services, NHS Blood and Transplant, London, UK.

Vox Sang ; 116(5): 493-496, 2021 05.

Article in English | MEDLINE | ID: covidwho-1388426

Keywords

COVID-19; ELISA; SUPPORT-E; convalescent plasma; neutralization

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Journal: Vox Sang Year: 2021 Document Type: Article Affiliation country: VOX.13060

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google